e/GSK716155

Information
has gloss	eng: GSK716155 (Albugon) is a recombinant Human Glucagon-like Peptide (GLP)-1-Albumin Protein created using Human Genome Sciences’ proprietary albumin fusion technology, which involves fusing the gene that expresses human albumin to the gene that expresses a therapeutically active protein (GLP-1)[1]. It is an agonist of the Glucagon-like Peptide-1 Receptor (GLP1R) and is currently undergoing clinical drug trials for treatment of Type 2 Diabetes Mellitus. The fusing of therapeutic proteins to human albumin decreases clearance and prolongs the half-life of therapeutically active proteins in the body[1].
lexicalization	eng: GSK716155
instance of	e/Antidiabetic drug